Navigation Links
Tolerx Advancing Novel Type 1 Diabetes Agent into Phase III Clinical Trial Program Following End of Phase II FDA Meeting
Date:4/9/2008

Phase III study will evaluate effects of otelixizumab, an investigational

anti-CD3 monoclonal antibody, on preservation of endogenous insulin

secretion

CAMBRIDGE, Mass., April 9, 2008 /PRNewswire/ - Tolerx, Inc., a biopharmaceutical company engaged in the discovery and development of novel therapies for immune-mediated diseases, today announced that it is proceeding toward the initiation of a Phase III study of otelixizumab in new-onset type 1 diabetes. Tolerx is initiating this pivotal trial after reviewing the results of the otelixizumab development program with the US Food and Drug Administration (FDA) at an End of Phase II meeting.

The Phase III study, known as DEFEND (Durable Response Therapy Evaluation For Early or New Onset Type 1 Diabetes), will be conducted at multiple centers in North America and Europe and will evaluate whether a single course of otelixizumab reduces the amount of administered insulin required for control of blood glucose levels by inhibiting destruction of beta cells. Maintenance of beta cell function has been associated with improved glycemic control (HbA1c levels), fewer hypoglycemic events and reduction of long term disease complications in established diabetics in the Diabetes Control and Complications Trial (DCCT). DEFEND enrollment is expected to begin mid-2008.

"We are very pleased with the outcome of the End of Phase II meeting with FDA and the opportunity to advance initiation of the DEFEND trial. This step is a significant and important milestone for Tolerx," said Dr. Douglas J. Ringler, President and Chief Executive Officer of Tolerx. "The rigorous science behind our Phase II clinical program has provided us with valuable insights that facilitated our moving forward into DEFEND with an optimized dosing regimen that has the potential to transform the treatment paradigm for type 1 diabetes."

"We have worked closely with FDA over several years to ensure that
'/>"/>

SOURCE Tolerx, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Tolerx Achieves Milestone with Completion of Phase Ib Clinical Study of TRX1 in Cutaneous Lupus Erythematosus
2. Novel Technology Breaks Through Cancer Pain
3. Iomai Trial Shows 100 Percent Immune Response in Elderly Subjects Vaccinated With Novel Travelers Diarrhea Patch Vaccine
4. Pharmacopeia Assists the World Health Organization in the Discovery of Novel Therapeutics for the Treatment of Malaria
5. Quark Pharmaceuticals Files Patent Application Covering Novel Chemical Modifications to its RNAi Molecules
6. Ardea Biosciences, Inc. Announces Completion of Phase 1 Clinical Trials of Novel Investigational HIV Drug RDEA806
7. The Lancet Publishes Major Phase 3 Study on Novel Oral Direct Thrombin Inhibitor
8. Study Results for Aclidinium Bromide, a Novel Anticholinergic, Presented at European Respiratory Society Annual Congress
9. Phase 2 Clinical Studies Initiated for a Novel Therapeutic Candidate Identified Through Pharmacopeia Collaboration
10. Oncology Drugs Development Update - Worldwide Markets and Forecasts of Approved EGFr/HEr2 Inhibitors, Treatment Costs, Pathway Analysis, Current and Expanded Clinical Indications, and Novel Agents in Development
11. ECLIPSE Data on Effects of Otsukas Investigational Novel Treatment, Tolvaptan, on Advanced Heart Failure Patients Hemodynamics and Urine Output Featured in Heart Failure Society of Americas Late Breaking Trials
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/3/2015)... Creekridge Capital, an independent, national commercial finance company, announced ... new sales representatives. Sam Puma has joined ... Stefanie Stark joined the company as a Relationship ... over 20 years of vendor and direct financing sales ... be responsible for identifying, implementing and growing Creekridge,s technology ...
(Date:6/3/2015)... June 02, 2015 Research and Markets  ( ... "Global Pharmaceutical Packaging Market 2015-2019" report to their ... grow at a CAGR of 5.9% over the period ... the market is the rise in demand for vials ... the second highest growth among all the segments at ...
(Date:6/3/2015)... 2015  (AHIP Institute Booth 1021) --  Availity , ... providing a wide range of information to help health ... America,s Health Insurance Plan,s (AHIP,s) 2015 Institute , June ... Availity released a special report to AHIP ... missed opportunities." The report identifies billions of ...
Breaking Medicine Technology:Creekridge Capital Strengthens Sales Team 2Global Pharmaceutical Packaging Market 2015-2019 with Amcor, Bemis Healthcare Packaging, Gerresheimer, MeadWestvaco, Owens-Illinois & West Pharmaceutical Services Dominating 2Availity to Share Insights, Tools and Strategies at AHIP 2015 to Enable Health Plans to Achieve Long-term, Sustainable Success in an Evolving Value-based Environment 2Availity to Share Insights, Tools and Strategies at AHIP 2015 to Enable Health Plans to Achieve Long-term, Sustainable Success in an Evolving Value-based Environment 3
... China, Dec. 27, 2011 /PRNewswire-Asia/ -- China Botanic ... ("China Botanic" or the "Company"), a developer, manufacturer ... Chinese Medicines ("TCM") in China, today announced that ... the 66th PHARMCHINA fair ("the Fair") recently held ...
... Reportlinker.com announces that a new ... its catalogue: Europe ... 2017- Glucose Monitoring and Insulin Delivery ... Europe Diabetes Care Devices ...
Cached Medicine Technology:China Botanic Exhibits All-Natural Anti-depressant Products at the 66th PHARMCHINA Fair 2China Botanic Exhibits All-Natural Anti-depressant Products at the 66th PHARMCHINA Fair 3Europe Diabetes Care Devices Market Outlook to 2017- Glucose Monitoring and Insulin Delivery 2Europe Diabetes Care Devices Market Outlook to 2017- Glucose Monitoring and Insulin Delivery 3Europe Diabetes Care Devices Market Outlook to 2017- Glucose Monitoring and Insulin Delivery 4Europe Diabetes Care Devices Market Outlook to 2017- Glucose Monitoring and Insulin Delivery 5Europe Diabetes Care Devices Market Outlook to 2017- Glucose Monitoring and Insulin Delivery 6Europe Diabetes Care Devices Market Outlook to 2017- Glucose Monitoring and Insulin Delivery 7Europe Diabetes Care Devices Market Outlook to 2017- Glucose Monitoring and Insulin Delivery 8Europe Diabetes Care Devices Market Outlook to 2017- Glucose Monitoring and Insulin Delivery 9Europe Diabetes Care Devices Market Outlook to 2017- Glucose Monitoring and Insulin Delivery 10Europe Diabetes Care Devices Market Outlook to 2017- Glucose Monitoring and Insulin Delivery 11Europe Diabetes Care Devices Market Outlook to 2017- Glucose Monitoring and Insulin Delivery 12
(Date:6/3/2015)... TN (PRWEB) June 03, 2015 According ... Inquisitr police officers intercepted fake oxycodone pills which ... pills were doctored to look legitimate, and even sported ... officers are warning those consuming 30 mg oxycodone to ... the pills online or buy them illegally on the ...
(Date:6/3/2015)... Implant design can have a profound ... unites bone to an implant surface. The unique triangular-shape ... to encourage bone regeneration, resulting in the gain of ... soft tissues for more esthetic restorations. , “It’s all ... MIS Implants. The triangular neck of the V3 provides ...
(Date:6/3/2015)... “ Scanalytics ” was featured on NewsWatch as ... latest and coolest technology products available to consumers. Andrew ... conducted the review and shared with viewers how this ... stores. , Tracking statistics in business is invaluable in ... retail this goes a step beyond revenue statistics and ...
(Date:6/3/2015)... 2015 Come on out in support ... 200-mile overnight relay beginning in Madison, Wisconsin on Friday, ... June 13th. , For the 4th consecutive year, a ... run to raise money for the Brain Aneurysm Foundation. ... of the Neurosurgery staff from The University of Illinois ...
(Date:6/3/2015)... (PRWEB) June 03, 2015 evigilo, a ... solutions, has showcased its new branding by launching a ... , "The new brand identity: the logo depicting a ... to green, the tagline – To Know. To Act. ... path evigilo is charting. A global, borderless approach to ...
Breaking Medicine News(10 mins):Health News:Fake Oxycodone Pills of Fentanyl Discovered in Tennessee by Police 2Health News:Fake Oxycodone Pills of Fentanyl Discovered in Tennessee by Police 3Health News:MIS Implants Launches Radically New V3 Dental Implant For Immediate Biological Benefits 2Health News:Technology to Analyze Foot Traffic in Retail Stores was featured on NewsWatch Television 2Health News:4th Annual Ragnar Relay from Madison, WI to Chicago, IL Once Again Benefits Renowned Brain Aneurysm Foundation 2Health News:Keep calm! evigilos' "sun" will come out tomorrow – to know, to act, in time. 2
... central districts of Kerala hospitalised with chikungunya fever, an infection ... to seek help from the central government. ,Reports from ... have died of high fever in the last three weeks. ... meeting on Friday to discuss this issue and June 12 ...
... debilitated thousands of World War I soldiers has been isolated ... international vacation. The woman, who has since recovered, suffered ... that can occur in returning travelers. ,But genetic ... bacterium that had never before been isolated from a human. ...
... MOHAN (Multi Organ Harvesting Aid Network) Foundation has organized a ... on 7th of June 2007. ,Organ donation is ... to another. Since 1994 in India almost twelve hundred transplants ... of the country. These donations take place after declaration of ...
... synthetic form of pramilintide hormone previously found to produce a ... also may help curb binge eating and the desire to ... of amylin, a satiety hormone produced by the beta cells ... Pramlintide treatment reduces 24-hour caloric intake and meal sizes and ...
... Researchers at the Translational Genomics Research Institute (TGen), ... collaborative partners, suggests that the gene ... Alzheimer's disease when associated with other genes, including ... common form of disabling memory and thinking problems ...
... away RMs Trophy for the Best Run Command Hospital under ... (Northern Command), Udhampur in New Delhi, today. Maj Gen Naresh ... cash award of Rs 2 lakhs. ,Speaking on ... by the Armed Forces Medical Services (AFMS) over the years ...
Cached Medicine News:Health News:New Bacterium Discovered - Related to Cause of Trench Fever 2Health News:New Bacterium Discovered - Related to Cause of Trench Fever 3Health News:New Bacterium Discovered - Related to Cause of Trench Fever 4Health News:Honoring of Organ Donor Families at Raj Bhavan in Chennai 2Health News:Pramlintide-A Boon to Restrain Fast Food Consumption 2Health News:Pramlintide-A Boon to Restrain Fast Food Consumption 3Health News:Pramlintide-A Boon to Restrain Fast Food Consumption 4Health News:Pramlintide-A Boon to Restrain Fast Food Consumption 5Health News:GAB2-A New Alzheimers Gene Identified 2Health News:GAB2-A New Alzheimers Gene Identified 3
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: